Navigation Links
CIMZIA(R) (certolizumab pegol), Significantly Reduces Structural Damage and Rheumatoid Arthritis Signs & Symptoms for Up to One Year

* 57.6*

ACR 50 3.1 32.5* 33.1*

ACR 70 0.8 15.9** 10.6+

*p<0.001 **p=0.002 +p=0.008

Six month mean mTSS changes from baseline for RAPID 2


(certolizumab (certolizumab

pegol) pegol)

Placebo & MTX 200mg & MTX 400mg & MTX

Six months 1.2 0.2** -0.4*

*p<0.001 **p=0.003

(a) ACR (American College of Rheumatology) response scores measure

improvement in the tender and swollen joint count and also include

assessment of the following five parameters: patient's global

assessment, physician's global assessment, patient's assessment of

pain, degree of disability, and level of acute-phase reactant. ACR20

is achieved when there is 20% improvement in the tender and swollen

joint count as well as a 20% improvement in at least three of the five

parameters. ACR50 & ACR70 are an extension of these criteria

corresponding to a 50% and 70% improvement respectively.(1)

(b) Modified Total Sharp Scores (mTSS) is a measurement used to assess

changes in bone erosion and joint-space narrowing measured by X-ray. A

smaller change in mTSS reflects less progression of joint damage.(2)

About Rheumatoid Arthritis

Rheumatoid arthritis (RA) is a progressive autoimmune disease that causes chronic inflammation of the joints. It is estimated that five million people suffer from RA globally,(3) with 0.3 percent to 1 percent of the population in industrialized countries suffering from RA.(4)

Prevalence is not split evenly between genders, since women are three times m

Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Study Suggests High-Dose Fish Oil May Significantly Improve Behavior in Children with ADHD
2. DEFLUX(R) Significantly Reduces Urinary Tract Infections in Children With Vesicoureteral Reflux
3. Vidaza Significantly Extends Overall Survival by 74% in Phase 3 Trial in Myelodysplastic Syndromes (MDS)
4. Nexavar Significantly Improved Overall Survival in Phase 3 Asia-Pacific Liver Cancer Trial
5. Study Shows Vasopressin Receptor Antagonist VAPRISOL(R) (Conivaptan Hydrochloride Injection) Significantly Increased Serum Sodium Concentration in Patients with Euvolemic & Hypervolemic Hyponatremia
6. New Data Reveal Topical Divigel(R) (estradiol gel) 0.1% Significantly Reduces Frequency and Severity of Hot Flashes
7. Promising Phase 3 Trial Results Show Novel Biologic Therapy Ustekinumab (CNTO 1275) Significantly Improved Psoriasis
8. INVEGA(TM) Significantly Reduced Symptoms of Schizophrenia Compared to SEROQUEL(R) in Acutely Ill, Hospitalized Patients
9. New Data Published in Neurology Show Once-Daily Lamictal XR Significantly Reduced Partial Seizures in Patients with Epilepsy
10. Anesiva Announces Pivotal Phase 3 Trial of Zingo(TM) Meets Primary Endpoint and Significantly Reduces Venous Access Pain in Adults
11. A Sociolinguistic Analysis of In-Office Dialogue Reveals Psychiatrists and Parents Have Significantly Different Perceptions on ADHD and Psychiatric Comorbidities
Post Your Comments:
(Date:8/29/2014)... 29, 2014 Research and Markets  has announced ... Insight 2014" report to their offering. ... one of the largest segments of pharmaceuticals industry. The numbers ... the available therapies were unable to meet the market requirements. ... for CNS disorder, especially over the past two decades. The ...
(Date:8/29/2014)... Md. , Aug. 29, 2014  United Therapeutics ... the U.S. District Court for the District of ... favor in the company,s case against Sandoz, Inc. regarding ... Peter Sheridan ruled that U.S. Patent No. ... and enjoined Sandoz from marketing its generic product until ...
(Date:8/29/2014)...  Unilife Corporation ("Unilife" or "Company") (NASDAQ: ... to release its financial results for the fiscal 2014 ... market trading ends on Tuesday, September 9, 2014. ... 4:30 p.m. U.S. EDT on Tuesday, September 9, 2014 ... the Company,s financial results, commercial partnerships, and future outlook.  ...
Breaking Medicine Technology:US CNS Disorders Drug Pipeline Insight 2014 2District Court Decision Received In Remodulin Patent Case 2Unilife Corporation to Announce Financial Results for Fiscal Year 2014 Fourth Quarter and Year End on Tuesday, September 9, 2014 2
... 2011 Express Scripts (Nasdaq: ESRX ), one ... announced today its intention to release its third quarter earnings ... will hold its quarterly conference call to discuss third quarter ... Time (8:30 a.m. Central Time). This call is ...
... U.S. Food and Drug Administration has issued a proposed ... classification for external pacemaker pulse generators from Class III ... ) External pacemaker pulse generators are ... permanent pacemaker can be implanted. They are also used ...
Cached Medicine Technology:FDA Proposes Lower Risk Classification, Special Controls for External Pacemakers 2FDA Proposes Lower Risk Classification, Special Controls for External Pacemakers 3
(Date:9/1/2014)... 01, 2014 An operating theatre or ... for performing surgical operations. An operating room comprises a ... booms, operating room lights, imaging displays as well as ... by Transparency Market Research, a U.S.-based market research firm, ... USD 4.5 billion by 2019. , According to ...
(Date:9/1/2014)... September 2014: Daily fruit consumption cuts the risk of ... research presented at ESC Congress today by Dr Huaidong ... year follow-up study of nearly 0.5 million people in ... people ate, the more their risk of CVD declined. ... (IHD) and stroke, is the leading cause of death ...
(Date:9/1/2014)... New York (PRWEB) September 01, 2014 ... store, retrieve, organize and analyze biological and genetic ... of the activity of developing software tools to ... not to be confused with biological computation. While ... better understanding of biology can its related concepts, ...
(Date:9/1/2014)... September 01, 2014 Ontraport , ... marketers that was developed to automate the small intricacies ... attention of Shane Michaels, prompting an investigative review. ... daily duty of managing all of the small details ... quite overwhelming,” reports Michaels. “That’s why Ontraport has become ...
(Date:9/1/2014)... Aliso Viejo, California (PRWEB) September 01, 2014 ... of a new tutorial video for the ProWorld Plugin from ... what Final Cut Pro X can do and users now ... own HDRI images.” Said Christina Austin, CEO of Pixel Film ... a definite game changer.” , Learn how to turn a ...
Breaking Medicine News(10 mins):Health News:Operating Room Equipment Market Study 2019 by Transparency Market Research 2Health News:Operating Room Equipment Market Study 2019 by Transparency Market Research 3Health News:Fruit consumption cuts CVD risk by up to 40 percent 2Health News:Fruit consumption cuts CVD risk by up to 40 percent 3Health News:Bioinformatics Market: A fusion of Computers and Biological Data 2Health News:Bioinformatics Market: A fusion of Computers and Biological Data 3Health News:Bioinformatics Market: A fusion of Computers and Biological Data 4Health News:Ontraport: Review Exposes Automated Platform for Online Marketing Management 2Health News:Pixel Film Studios Released a New Tutorial Entitled ProWorld Lesson Exclusively for Final Cut Pro X 2
... (HealthDay News) -- Scientists say they,ve learned why a ... bland supermarket variety. The University of Florida researchers ... heirloom varieties, most of which were bred before today,s ... large chemical diversity. The researchers than had ...
... News) -- Women with advanced breast cancer who have higher ... women with lower levels of fitness during treatment, new research ... and lung function, according to the study by researchers at ... years after treatment has ended. Among those with advanced ...
... News) -- Only one in 14 Hispanic adults in the ... fewer than the one in four whites screened, a new ... insurance and poorer access to health care services are major ... Cancer Institute of New Jersey. They added that their ...
... from the University of California, San Diego and its ... in new grants from the California Institute for Regenerative ... spinal cord injuries, repairing gene mutations that cause amyotrophic ... failure and Alzheimer,s disease. The awards mark the ...
... An overactive BAALC gene in acute leukemia cells identifies patients ... This study discovered why the gene is often overactive., ... guide therapy in these patients. COLUMBUS, Ohio ... overactivating a gene linked to poor treatment response in people ...
... YORK, May 25, 2012 Ben-Gurion University of the ... the desert with the successful application of a solar-powered ... regions. The project was made possible with support from ... The solar-powered system uses nanofiltration membranes to treat the ...
Cached Medicine News:Health News:Fitness May Boost Survival for Women With Breast Cancer 2Health News:Few U.S. Hispanics Screened for Skin Cancer 2Health News:UC San Diego researchers receive new CIRM funding 2Health News:UC San Diego researchers receive new CIRM funding 3Health News:Inherited DNA change explains overactive leukemia gene 2Health News:Ben-Gurion U. researchers successfully test solar desalination system for arid land agriculture 2
Curved shafts with 0.5 mm, 1 x 2 teeth. Serrated handle with thumb catch lock and polished finish....
Narrow 12 mm jaws with fine teeth. Serrated handle with polished finish....
Straight shafts with heavy Elschnig teeth. Flat serrated handle with slide style lock and polished finished....
Straight shafts with delicate 0.7 mm, 1 x 2 teeth. Serrated handle with polished finish....
Medicine Products: